Chicago is in the midst of a biotech influx, with expansive lab space planned for development. The recent growth can be largely attributed to a year focused on science and medical advancement due to the pandemic. Innovative life science leaders, like Jeff Aronin, continue to expand and launch companies, investing in the city even during a challenging year.
Paragon Biosciences Founder, Chairman and CEO Jeff Aronin discusses Chicago’s rapid life sciences expansion and the need for innovation to solve some of the world’s greatest challenges.
Access the entire interview here: